Literature DB >> 8886421

The effect of PPADS as an antagonist of inositol (1,4,5)trisphosphate induced intracellular calcium mobilization.

P Vigne1, P Pacaud, V Urbach, E Feolde, J P Breittmayer, C Frelin.   

Abstract

1. Brain capillary endothelial cells responded to uridine 5'-triphosphate (UTP) and adenosine 5'-triphosphate (ATP) by activation of phospholipase C and by large changes in [Ca2+]i. These cells expressed mRNA sequences identical to the sequence of the P2Y2-purinoceptor of rat pituitaries. 2. Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) at 100 microM did not prevent UTP and ATP induced accumulations of total [3H]-inositol (poly)phosphates. It inhibited UTP and ATP induced intracellular Ca2+ mobilization (IC50 = 30 microM) by non competitive mechanism. 3. PPADS (100 microM) inhibited endothelin-1 induced accumulation of total [3H]-inositol (poly)phosphates by less than 20% and prevented most of endothelin-1 induced intracellular Ca2+ mobilization (IC50 = 30 microM). 4. PPADS (100 microM) had no action on ionomycin induced intracellular Ca2+ mobilization. 5. Microinjection of inositol (1,4,5)trisphosphate (InsP3) into Xenopus oocytes induced large Ca2+ activated Cl- currents that were prevented by heparin and by PPADS. 6. It is concluded that PPADS does not recognize rat P2Y2-purinoceptors and prevents UTP and ATP induced intracellular Ca2+ mobilization by a non-specific mechanism that could involve the inhibition of InsP3 channels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886421      PMCID: PMC1915870          DOI: 10.1111/j.1476-5381.1996.tb15994.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Effects of the level of mRNA expression on biophysical properties, sensitivity to neurotoxins, and regulation of the brain delayed-rectifier K+ channels Kv1.2.

Authors:  E Guillemare; E Honoré; L Pradier; F Lesage; H Schweitz; B Attali; J Barhanin; M Lazdunski
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

2.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

Authors:  G Lambrecht; T Friebe; U Grimm; U Windscheif; E Bungardt; C Hildebrandt; H G Bäumert; G Spatz-Kümbel; E Mutschler
Journal:  Eur J Pharmacol       Date:  1992-07-07       Impact factor: 4.432

3.  A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.

Authors:  C Ho; J Hicks; M W Salter
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  ADP induces inositol phosphate-independent intracellular Ca2+ mobilization in brain capillary endothelial cells.

Authors:  C Frelin; J P Breittmayer; P Vigne
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

Review 5.  Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.

Authors:  G R Dubyak; C el-Moatassim
Journal:  Am J Physiol       Date:  1993-09

6.  Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.

Authors:  G Guillemette; S Lamontagne; G Boulay; B Mouillac
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

7.  Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells.

Authors:  P Vigne; R Marsault; J P Breittmayer; C Frelin
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

8.  Inositol tetrakisphosphate liberates stored Ca2+ in Xenopus oocytes and facilitates responses to inositol trisphosphate.

Authors:  I Parker; I Ivorra
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

9.  PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.

Authors:  A U Ziganshin; C H Hoyle; X Bo; G Lambrecht; E Mutschler; H G Bäumert; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Competitive and non competitive interactions of BQ-123 with endothelin ETA receptors.

Authors:  P Vigne; J P Breittmayer; C Frelin
Journal:  Eur J Pharmacol       Date:  1993-05-15       Impact factor: 4.432

View more
  5 in total

1.  Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals.

Authors:  B Sperlágh; F Erdélyi; G Szabó; E S Vizi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Characterization of Calcium-Mediated Intracellular and Intercellular Signaling in the rMC-1 Glial Cell Line.

Authors:  Diana Yu; Marius Buibas; Siu-Kei Chow; Ian Y Lee; Zakary Singer; Gabriel A Silva
Journal:  Cell Mol Bioeng       Date:  2009-03-01       Impact factor: 2.321

Review 3.  Interplay between renal endothelin and purinergic signaling systems.

Authors:  Eman Y Gohar; Malgorzata Kasztan; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2017-02-08

4.  Both RyRs and TPCs are required for NAADP-induced intracellular Ca²⁺ release.

Authors:  Julia V Gerasimenko; Richard M Charlesworth; Mark W Sherwood; Pawel E Ferdek; Katsuhiko Mikoshiba; John Parrington; Ole H Petersen; Oleg V Gerasimenko
Journal:  Cell Calcium       Date:  2015-06-10       Impact factor: 6.817

5.  UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery.

Authors:  Zainab S B Abbas; M Liaque Latif; Natalia Dovlatova; Sue C Fox; Stan Heptinstall; William R Dunn; Vera Ralevic
Journal:  Vascul Pharmacol       Date:  2017-12-15       Impact factor: 5.773

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.